| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.889752 |
| 003 | CaOODSP |
| 005 | 20221107172402 |
| 006 | m o d f |
| 007 | cr ||||||||||| |
| 008 | 200724t20202020onc ob f00| 0 eng d |
| 020 | |a9780660356440 |
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
| 043 | |an-cn--- |
| 086 | 1 |aHP40-272/2020E-PDF |
| 245 | 00|aMammalian cell culture-based influenza vaccines : |bsupplemental statement. |
| 264 | 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2020. |
| 264 | 4|c©2020 |
| 300 | |a1 online resource (70 pages) |
| 336 | |atext|btxt|2rdacontent |
| 337 | |acomputer|bc|2rdamedia |
| 338 | |aonline resource|bcr|2rdacarrier |
| 500 | |aIssued also in French under title: Vaccins antigrippaux issus de cultures cellulaires de mammifères : déclaration supplémentaire. |
| 500 | |aCover title. |
| 500 | |a"An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)." |
| 500 | |a"Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2020–2021." |
| 500 | |aIssued also in HTML format. |
| 504 | |aIncludes bibliographical references (pages 64-67). |
| 650 | 0|aInfluenza vaccines|zCanada. |
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
| 775 | 08|tVaccins antigrippaux issus de cultures cellulaires de mammifères : |w(CaOODSP)9.889753 |
| 856 | 40|qPDF|s2.57 MB|uhttps://publications.gc.ca/collections/collection_2020/aspc-phac/HP40-272-2020-eng.pdf |
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/mammalian-cell-culture-based-influenza-vaccines.html |
| 986 | |a200143 |